EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte Studie

Randomized Placebo-Controlled Trial of Topical Capsaicin for Delayed Chemotherapy-Induced Nausea and Vomiting

Heber Rew Bright iD, Ashish Singh iD, Anjana Joel iD, Josh Thomas Georgy iD, Ajoy Oommen John iD, Pradeep Rajkumar, Hema Jiji, Lisa Stehno-Bittel, Prasanna Samuel, Sujith J Chandy iD

JCO Global Oncology · 2024

DOI: 10.1200/go.24.00130 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JCO Global Oncology, 2024. Verfasst von Heber Rew Bright und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Christian Medical College, Vellore, India. Hauptthemen laut MEDLINE: Capsaicin, Vomiting, Nausea. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE We examined the efficacy of topical capsaicin in reducing delayed chemotherapy-induced nausea and vomiting (CINV). METHODS Adults on highly emetogenic chemotherapy regimens applied 2 g of capsaicin ointment (0.075%) or matching placebo four times a day to the abdomen for 5 days in addition to standard antiemetic regimen in this blinded randomized controlled trial. Patients were monitored for nausea and vomiting in the immediate (day 1), delayed (days 2-5), and extended phases (days 2-15). Self-reported incidence and daily episodes of CINV were compared between the groups. Onset, severity, need for rescue antiemetics, cumulative vomiting episodes, and safety were also compared. RESULTS In total, 160 patients were enrolled. The final modified intention-to-treat population included 75 patients each in the capsaicin and placebo groups. Fewer patients experienced nausea (36.0% [n = 27] v 53.3% [n = 40]; P = .033) and vomiting (28.0% [n = 21] v 42.7% [n = 32]; P = .060) in the capsaicin arm during the delayed phase. During the extended phase, there was a significantly lower incidence of nausea (44% v 64.0%; P = .014) in the capsaicin arm. No difference in nausea (26.7% v 25.3%) or vomiting (22.7% v 18.7%) was evident in the immediate phase. The average daily episodes of nausea and vomiting were significantly fewer in the capsaicin arm during the delayed and extended phases. With capsaicin, no grade 3 nausea (9.3% v 0.0%; P = .007) was observed, and the time to first nausea and vomiting was significantly prolonged. There were no differences between the groups with respect to rescue antiemetics, unscheduled hospital visits, and adverse events. CONCLUSION Topical capsaicin reduced the incidence of nausea and the average number of vomiting episodes during delayed and extended phases without increasing adverse effects.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CapsaicinVomitingNauseaHumansMaleFemaleMiddle AgedAdultAdministration, TopicalAgedAntineoplastic AgentsAntiemeticsNeoplasms

Substanzen

CapsaicinAntineoplastic AgentsAntiemetics

Autor:innen und Institutionen

  • Department of Pharmacy, Christian Medical College, Vellore, India.
  • Department of Medical Oncology, Christian Medical College, Vellore, India.
  • Likarda, Inc, Kansas City, MO.
  • University of Kansas Medical Center, Rehabilitation Science, Kansas City, KS.
  • Department of Biostatistics, Christian Medical College, Vellore, India.
  • Department of Pharmacology and Clinical Pharmacology, Christian Medical College, Vellore, India.

ORCID-Profile: Heber Rew Bright, Ashish Singh, Anjana Joel, Josh Thomas Georgy, Ajoy Oommen John, Sujith J Chandy

Zitieren

APA

Bright, H. R., Singh, A., Joel, A., Georgy, J. T., John, A. O., Rajkumar, P., Jiji, H., Stehno-Bittel, L., Samuel, P., & Chandy, S. J. (2024). Randomized Placebo-Controlled Trial of Topical Capsaicin for Delayed Chemotherapy-Induced Nausea and Vomiting. JCO Global Oncology. https://doi.org/10.1200/go.24.00130

Vancouver

Bright HR, Singh A, Joel A, Georgy JT, John AO, Rajkumar P, et al. Randomized Placebo-Controlled Trial of Topical Capsaicin for Delayed Chemotherapy-Induced Nausea and Vomiting. JCO Global Oncology. 2024. doi:10.1200/go.24.00130

BibTeX
@article{Bright2024,
  author = {Bright, Heber Rew and Singh, Ashish and Joel, Anjana and Georgy, Josh Thomas and John, Ajoy Oommen and Rajkumar, Pradeep and Jiji, Hema and Stehno-Bittel, Lisa and Samuel, Prasanna and Chandy, Sujith J},
  title = {Randomized Placebo-Controlled Trial of Topical Capsaicin for Delayed Chemotherapy-Induced Nausea and Vomiting},
  journal = {JCO Global Oncology},
  year = {2024},
  doi = {10.1200/go.24.00130}
}
Kostenlos starten →